LLNL featured at innovation forum
Panelists responded to questions from moderator Peter Burrows, senior writer for Bloomberg Businessweek, as well as the audience, on the state of innovation in the region. Turteltaub commented on the Institute for Translational Biomedicine (ITB), a new Livermore and Sandia venture that brings together public and private entities to help accelerate and improve the success rate for the development of new pharmaceuticals, medical devices and biosecurity technologies. ITB is one of several new collaboration efforts in the Livermore Valley Open Campus.
Other panelists included Ro Khanna, former deputy assistant secretary for U.S. and Foreign Commercial Service at the Department of Commerce, Anthony Zografos, COO of Compact Particle Acceleration Corporation, Christine Wente of Wente Vineyards and Carl Guardino, president and CEO of the Silicon Valley Leadership Group.